IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $64,997,168 | -60.7% | 6,178,438 | -53.7% | 0.01% | -60.6% |
| Q4 2022 | $165,287,271 | +15.1% | 13,340,377 | -3.7% | 0.03% | +6.5% |
| Q3 2022 | $143,569,000 | -16.5% | 13,858,069 | -7.1% | 0.03% | -11.4% |
| Q2 2022 | $172,005,000 | -9.9% | 14,917,954 | -1.7% | 0.04% | +6.1% |
| Q1 2022 | $190,984,000 | -5.3% | 15,181,647 | -12.2% | 0.03% | +3.1% |
| Q4 2021 | $201,721,000 | -11.7% | 17,300,305 | -1.1% | 0.03% | -17.9% |
| Q3 2021 | $228,563,000 | -15.8% | 17,501,021 | -17.0% | 0.04% | -13.3% |
| Q2 2021 | $271,488,000 | +14.6% | 21,094,651 | -0.4% | 0.04% | +7.1% |
| Q1 2021 | $236,897,000 | -3.8% | 21,189,305 | -2.0% | 0.04% | -6.7% |
| Q4 2020 | $246,226,000 | +22.9% | 21,617,713 | -3.0% | 0.04% | +9.8% |
| Q3 2020 | $200,366,000 | -12.6% | 22,275,154 | +0.3% | 0.04% | -19.6% |
| Q2 2020 | $229,298,000 | +3.0% | 22,218,859 | +0.7% | 0.05% | -13.6% |
| Q1 2020 | $222,629,000 | -23.0% | 22,064,270 | +1.6% | 0.06% | -3.3% |
| Q4 2019 | $289,141,000 | +55.0% | 21,723,672 | -0.0% | 0.06% | +45.2% |
| Q3 2019 | $186,529,000 | -21.5% | 21,727,162 | -0.0% | 0.04% | -20.8% |
| Q2 2019 | $237,700,000 | -18.7% | 21,727,703 | +0.6% | 0.05% | -19.7% |
| Q1 2019 | $292,218,000 | +44.3% | 21,597,829 | +10.5% | 0.07% | +29.4% |
| Q4 2018 | $202,532,000 | -43.5% | 19,549,341 | +0.6% | 0.05% | -32.9% |
| Q3 2018 | $358,735,000 | -2.6% | 19,433,137 | +0.9% | 0.08% | -7.3% |
| Q2 2018 | $368,312,000 | +24.8% | 19,263,267 | +0.7% | 0.08% | +22.4% |
| Q1 2018 | $295,205,000 | +4.1% | 19,131,830 | +1.1% | 0.07% | +6.3% |
| Q4 2017 | $283,622,000 | -4.7% | 18,920,796 | +0.2% | 0.06% | -7.4% |
| Q3 2017 | $297,742,000 | -15.8% | 18,880,187 | +0.7% | 0.07% | -18.1% |
| Q2 2017 | $353,805,000 | +11.6% | 18,739,689 | +0.9% | 0.08% | +9.2% |
| Q1 2017 | $317,001,000 | +13.1% | 18,581,554 | +1.4% | 0.08% | +8.6% |
| Q4 2016 | $280,312,000 | -2.9% | 18,333,040 | +0.8% | 0.07% | -2.8% |
| Q3 2016 | $288,717,000 | +22.8% | 18,181,157 | +1.1% | 0.07% | +18.0% |
| Q2 2016 | $235,055,000 | +20.4% | 17,977,429 | +0.8% | 0.06% | +19.6% |
| Q1 2016 | $195,206,000 | -5.3% | 17,843,324 | +0.4% | 0.05% | -5.6% |
| Q4 2015 | $206,050,000 | +11.7% | 17,778,210 | +0.4% | 0.05% | +5.9% |
| Q3 2015 | $184,461,000 | -13.2% | 17,702,552 | +0.4% | 0.05% | -7.3% |
| Q2 2015 | $212,589,000 | -24.2% | 17,627,533 | +0.6% | 0.06% | -23.6% |
| Q1 2015 | $280,467,000 | +5.9% | 17,529,199 | +1.4% | 0.07% | +2.9% |
| Q4 2014 | $264,871,000 | +20.8% | 17,289,225 | +2.2% | 0.07% | +16.7% |
| Q3 2014 | $219,216,000 | -14.5% | 16,921,306 | +1.2% | 0.06% | -13.0% |
| Q2 2014 | $256,432,000 | +25.1% | 16,727,455 | +0.5% | 0.07% | +21.1% |
| Q1 2014 | $205,061,000 | +29.6% | 16,644,557 | +22.2% | 0.06% | +26.7% |
| Q4 2013 | $158,190,000 | +0.0% | 13,625,326 | +2.1% | 0.04% | -10.0% |
| Q3 2013 | $158,138,000 | +20.4% | 13,344,947 | +1.1% | 0.05% | +16.3% |
| Q2 2013 | $131,321,000 | – | 13,198,186 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |